Frequency of BCL2 and BCL6 translocations in follicular lymphoma:: Relation with histological and clinical features

被引:33
作者
Diaz-Alderete, Andrea [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Doval, Angela [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Camacho, Francisca [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Verde, Lydia [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Sabin, Pilar [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Arranz-Saez, Reyes [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Bellas, Carmen [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Corbacho, Carlos [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Gil, Juana [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Perez-Martin, Maria [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Ruiz-Marcellan, Maria [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Gonzalez, Leocricia [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Montalban, Carlos [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Piris, Miguel [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Menarguez, Javier [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Immunol, Madrid, Spain
[3] Mol Pathol Prog, Madrid, Spain
[4] CNIO, Immunohistochem Unit, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Dept Oncol, Madrid, Spain
[6] Hosp Princesa, Dept Hematol, Madrid, Spain
[7] Hosp Puerta Hierro, Dept Pathol, Madrid, Spain
[8] Hosp Doce Octubre, Dept Pathol, Madrid, Spain
[9] Hosp Valle De Hebron, Dept Pathol, Madrid, Spain
[10] Hosp Ramon & Cajal, Dept Internal Med, E-28034 Madrid, Spain
关键词
cytogenetics; lymphoma and Hodgkin disease; morphology;
D O I
10.1080/10428190701742472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Follicular lymphomas (FLs) usually carry BCL2 translocations although BCL6 translocations are also present. We explored relationships between translocations status and clinical or histological parameters at diagnosis in 182 patients stratified in four groups: BCL2-/BCL6-, BCL2+/BCL6-, BCL2-/BCL6+ and BCL2+/BCL6+. BCL2-/BCL6- and BCL2+/BCL6-. Double negative cases were ascribed to lower histological grades. In contrast, BCL2-/BCL6+ cases corresponded to higher grades. However, a majority of BCL2+/BCL6+ tumours were classified as lower grades. These results were reinforced by the finding that double positive patients had lower LDH levels and PS than those with solitary BCL6 rearrangements. Bone marrow involvement was more frequent in BCL2+/BCL6+ compared with BCL2-/BCL6+ tumours. Our data confirm the presence of a relationship between histological grade and translocation status, suggesting that FLs carrying BCL6 translocations probably constitute a special biological subtype. Clinical and histological differences between BCL2-/BCL6+ and BCL2+/BCL6+ tumours could reflect an interplay between both translocations.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 28 条
[1]  
Alvaro T, 2006, HAEMATOLOGICA, V91, P1605
[2]   Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment [J].
Arcaini, L ;
Colombo, N ;
Passamonti, F ;
Burcheri, S ;
Orlandi, E ;
Brusamolino, E ;
Della Porta, M ;
Rumi, E ;
Montanari, F ;
Pascutto, C ;
Paulli, M ;
Lazzarino, M .
LEUKEMIA RESEARCH, 2006, 30 (03) :277-282
[3]   New approach to classifying non-hodgkin's lymphomas: Clinical features of the major histologic subtypes [J].
Armitage, JO ;
Weisenburger, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2780-2795
[4]   Insights into the molecular pathogenesis of follicular lymphoma, arising from analysis of geographic variation [J].
Biagi, JJ ;
Seymour, JF .
BLOOD, 2002, 99 (12) :4265-4275
[5]   Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? [J].
Bosga-Bouwer, AG ;
van den Berg, A ;
Haralambieva, E ;
de Jong, D ;
Boonstra, R ;
Kluin, P ;
van den Berg, E ;
Poppema, S .
HUMAN PATHOLOGY, 2006, 37 (05) :528-533
[6]   Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints.: An underused diagnostic alternative [J].
Buño, I ;
Nava, P ;
Alvarez-Doval, A ;
Alvarez-Rodríguez, F ;
Díez-Martín, JL ;
Menárguez, J .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (06) :629-633
[7]   The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome [J].
Buske, Christian ;
Hoster, Eva ;
Dreyling, Martin ;
Hasford, Joerg ;
Unterhalt, Michael ;
Hiddemann, Wolfgang .
BLOOD, 2006, 108 (05) :1504-1508
[8]   Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice [J].
Cattoretti, G ;
Pasqualucci, L ;
Ballon, G ;
Tam, W ;
Nandula, SV ;
Shen, Q ;
Mo, TW ;
Murty, VV ;
Dalla-Favera, R .
CANCER CELL, 2005, 7 (05) :445-455
[9]   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].
Dave, SS ;
Wright, G ;
Tan, B ;
Rosenwald, A ;
Gascoyne, RD ;
Chan, WC ;
Fisher, RI ;
Braziel, RM ;
Rimsza, LM ;
Grogan, TM ;
Miller, TP ;
LeBlanc, M ;
Greiner, TC ;
Weisenburger, DD ;
Lynch, JC ;
Vose, J ;
Armitage, JO ;
Smeland, EB ;
Kvaloy, S ;
Holte, H ;
Delabie, J ;
Connors, JM ;
Lansdorp, PM ;
Ouyang, Q ;
Lister, TA ;
Davies, AJ ;
Norton, AJ ;
Muller-Hermelink, HK ;
Ott, G ;
Campo, E ;
Montserrat, E ;
Wilson, WH ;
Jaffe, ES ;
Simon, R ;
Yang, LM ;
Powell, J ;
Zhao, H ;
Goldschmidt, N ;
Chiorazzi, M ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169